Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
57%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
62%
ALSO IN THNR
THNR
19
HOLDINGS
68%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
NOVO-NORDISK A/S-SPONS ADR | 12.2% | 9.0% | 9.0% |
 |
ELI LILLY & CO | 11.7% | 8.4% | 8.4% |
 |
CHINA PHARMACEUTICAL GROUP | 7.1% | 5.9% | 5.9% |
|
PFIZER INC | 7.3% | 4.9% | 4.9% |
|
VIKING THERAPEUTICS, INC. | 5.1% | 4.7% | 4.7% |
OZEM Overweight Relative to THNR
 |
ASCLETIS PHARMA, INC. | 3.8% |
|
ELI LILLY & CO | 3.3% |
|
NOVO-NORDISK A/S-SPONS ADR | 3.2% |
|
MBX BIOSCIENCES INC | 3.0% |
 |
HANSOH PHARMACEUTICAL GROUP COMPANY | 3.0% |
|
KAILERA THERAPEUTICS INC | 2.7% |
|
THE UNITED LABORATORIES INTE | 2.5% |
|
PFIZER INC | 2.4% |
|
GILEAD SCIENCES INC | 2.0% |
 |
HANMI PHARM CO LTD | 2.0% |
OZEM Underweight Relative to THNR
|
REGENERON PHARMACEUTICALS | -6.1% |
|
MERCK & CO. INC. | -5.5% |
|
SCHOLAR ROCK HOLDING CORP. | -5.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -5.1% |
|
ABBVIE INC | -5.0% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.2% |
|
INNOVENT BIOLOGICS, INC. | -3.2% |
|
AMGEN INC | -1.1% |
 |
ASTRAZENECA PLC | -0.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 0.0% |